Related Experiment Video
Updated: Aug 15, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
UV light-induced dual promoter mutations dismantle the telomeric guardrails in melanoma
Samantha L Sanford1, Patricia L Opresko2
1Department of Environmental and Occupational Health, University of Pittsburgh School of Public Health, USA; UPMC Hillman Cancer Center, University of Pittsburgh, 5117 Centre Avenue, Pittsburgh, PA 15213, USA.
Abstract:
Understanding how benign nevi can progress to invasive and metastatic Department of Environmental and Occupational Health, University of Pittsburgh School of Public Health, USAelanoma is critical for developing interventions and therapeutics for this most deadly form of skin cancer. UV-induced mutations in the telomerase TERT gene promoter occur in the majority of melanomas but fail to prevent telomere shortening despite telomerase upregulation. This suggests additional "hits" are required to enable telomere maintenance. A new study in Science identified somatic variants in the promoter of the gene that encodes telomere shelterin protein TPP1 in human melanomas. These variants show mutational signatures of UV-induced DNA damage and upregulate TPP1 expression, which synergizes with telomerase to lengthen telomeres. This study provides evidence that TPP1 promoter variants are a critical second hit to prevent telomere shortening and promote immortalization of melanoma cells.
Insights
Somatic variants in the TPP1 gene promoter act as a critical second hit in melanoma development. These UV-induced mutations cooperate with telomerase to enable telomere maintenance and melanoma cell immortalization.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Melanoma progression from benign nevi requires mechanisms for telomere maintenance.
- UV radiation is a primary driver of melanoma, causing mutations in genes like TERT.
- Telomerase upregulation alone is insufficient for melanoma cell immortalization due to persistent telomere shortening.
Purpose of the Study:
- To investigate additional genetic alterations enabling telomere maintenance in melanoma.
- To identify novel genetic hits beyond TERT promoter mutations in melanoma development.
Main Methods:
- Analysis of somatic variants in human melanoma genomes.
- Examination of TPP1 gene promoter mutations and their functional consequences.
- Assessment of TPP1 expression and its synergistic effect with telomerase on telomere length.
Main Results:
- Somatic variants were identified in the promoter of the TPP1 gene in human melanomas.
- These TPP1 promoter variants exhibit UV-induced DNA damage mutational signatures.
- TPP1 promoter variants upregulate TPP1 expression, synergizing with telomerase to lengthen telomeres.
Conclusions:
- TPP1 promoter variants represent a critical second hit in melanoma pathogenesis.
- These variants contribute to telomere maintenance and melanoma cell immortalization.
- Targeting TPP1 may offer new therapeutic strategies for melanoma treatment.
Related Concept Videos
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Spontaneous and Induced Mutations
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Non-LTR Retrotransposons

